RHPN2 and prostate carcinoma: The upregulated miR-205 inhibited the proliferation, invasion, and migration of prostate cancer cells and promoted apoptosis by targeting RHPN2, and this was effected through miR-205-expressing exosomes derived from human bone marrow mesenchymal stem cells.